Z vs GENI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 30, 2026

Z

39.4
AI Score
VS
GENI Wins

GENI

63.4
AI Score

Investment Advisor Scores

Z

39score
Recommendation
AVOID NEW MONEY

GENI

63score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric Z GENI Winner
Forward P/E 9.9206 51.0204 Z
PEG Ratio 0.9315 0 Tie
Revenue Growth 17.9% 64.7% GENI
Earnings Growth 533.3% 0.0% Z
Tradestie Score 39.4/100 63.4/100 GENI
Profit Margin 2.0% -23.0% Z
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD GENI

Relative Price Performance (Last 90 Days)

Z 1M: -20.7% · 3M: -16.8% GENI 1M: -18.9% · 3M: -9.1%

Current Technical Phase

Z

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.5%), weak momentum, RSI 34

RSI (14): 34.2 · Price: $27.41

GENI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 43

RSI (14): 42.9 · Price: $6.02

Fundamentals Snapshot

Metric Z GENI
Market Cap — —
Forward P/E 9.8 5.6
Trailing P/E 115.6 —
Revenue (TTM) — —
Revenue Growth 0.2% 0.6%
Gross Margin 0.7% 0.3%
Operating Margin 0.0% -0.1%
EPS 0.24 -0.66
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, GENI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.